Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Nurix Therapeutics Inc shares valued at $82,250 were sold by Ring Christine on Oct 14 ’24. At $25.00 per share, Ring Christine sold 3,290 shares. The insider’s holdings dropped to 24,592 shares worth approximately $0.61 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Ring Christine sold 5,760 shares, netting a total of over 128,017 in proceeds. Following the sale of shares at $22.23 each, the insider now holds 24,592 shares.
Before that, CHRISTINE RING had added 9,050 shares to its account. In a trade valued at $203,354, the Officer bought Nurix Therapeutics Inc shares for $22.47 each.
As published in their initiating research note from Jefferies on October 11, 2024, Nurix Therapeutics Inc [NRIX] has been a Buy and the price target has been revised to $41. As of July 31, 2024, Truist has initiated its “Buy” rating for NRIX.
Analyzing NRIX Stock Performance
During the last five days, there has been a surge of approximately 13.08%. Over the course of the year, Nurix Therapeutics Inc shares have jumped approximately 139.53%. Shares of the company reached a 52-week high of $26.43 on 10/17/24 and a 52-week low of $7.65 on 01/29/24. A 50-day SMA is recorded $23.54, while a 200-day SMA reached $16.88. Nevertheless, trading volume fell to 1.82 million shares from 0.76 million shares the previous day.
Support And Resistance Levels for Nurix Therapeutics Inc (NRIX)
According to the 24-hour chart, there is a support level at 24.02, which, if violated, would cause prices to drop to 23.33. In the upper region, resistance lies at 25.92. The next price resistance is at 27.12. RSI (Relative Strength Index) is 57.01 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.13, which suggests the price will increase in the coming days. Percent R is at 31.88%, indicating low price movement. Stochastics %K at selling indicates that the stock is to be held.
